Below is a listing of treatments and therapies for amyloidosis. Click on one to read more information or connect with others currently using it.
Overview
Amvuttra is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with hereditary transthyretin-mediated (hATTR) amyloidosis who have polyneuropathy (nerve damage). Amvuttra…
Overview
Vyndamax is approved by the U.S. Food and Drug Administration (FDA) for the treatment of cardiomyopathy (heart muscle disease) caused by wild-type or hereditary transthyretin-mediated amyloidosis. This treatment…
Become a member to get even more